Myeloid leukemia after hematotoxins

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 6, 1996, Pages 1303-1307

  Larson, Richard A ^a   LeBeau, Michelle M ^a   Vardiman, James W ^a   Rowley, Janet D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

AML1 gene; Cancer therapy; Chromosome rearrangement; Leukemia; MLL gene; Secondary cancers

Indexed keywords

ALKYLATING AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER THERAPY; CHROMOSOME 11Q; CHROMOSOME 21Q; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; DISEASE COURSE; GENE REARRANGEMENT; HUMAN; LATENT PERIOD; METASTASIS; MYELOID LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; RADIATION INJURY;

EID: 0030472726     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041303     Document Type: Conference Paper

References (32)

1. Koeffler HP, Rowley JD. Therapy-related acute nonlymphocytic leukemia. In: Neoplastic Diseases of the Blood (Wiernick PH, Canellos CP, Kyle RA, Schiffer CA, eds). New York:Churchill Livingstone, 1985; 357-381.
2. Ionizing Radiation - Levels and Effects. A Report of the United Nations Scientific Committee on the Effects of Atomic Radiation. New York:United Nations, 1972.
3. Le Beau MM, Albain KS, Larson RA. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 4:325-345 (1986).
4. Henry-Amar M, Dietrich P-Y. Acute leukemia after the treatment of Hodgkin's disease. Hematol Oncol Clin North Am 7:369-387 (1993).
5. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19:471 (1992).
6. Butler AE, Vardiman JW, Golomb HM. Ultrastructural characterization of de novo and secondary leukemias. Virchows Arch [B] 39:239-257 (1982).
7. Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 65:1364-1372 (1985).
8. Larson RA, Wernli M, Le Beau MM, Daly KM, Pape LH, Rowley JD, Vardiman JW. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood 72:1333-1339 (1988).
9. Fourth International Workshop on Chromosomes in Leukemia 1982: Secondary Leukemias Associated with Neoplasia: Treated and Untreated. Cancer Genet Cytogenet 11:319-321 (1984).
10. Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 4(12):1748-1757 (1986).
11. Pedersen-Bjergaard J, Philip P, Larsen SO, et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 7(12):1975-1986 (1993)
12. Rubin CM, Arthur DC, Woods WG. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood 78(11):2982-2988 (1991).
13. Larson RA, Le Beau MM, Ratain MJ, Rowley JD. Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia. Blood 79(7): 1892-1893 (1992).
14. Pedersen-Bjergaard J, Philip P. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase. II. Blood 78:1147-1148 (1991).
15. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83(10):2780-2786 (1994).
16. Pui CH, Ribeiro R, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682-1687 (1991).
17. Ratain MJ, Kaminer LS, Bitran JD, Larson RA, Le Beau MM, Skosey C, Purl S, Hoffman PC, Wade J, Vardiman JW, et al. Acute nonlymphocytic leukemia following etoposide and cis-platin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 70:1412 (1987).
18. Ratain MJ, Rowley JD. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase. II: from the bedside to the target genes. Ann Oncol 3(2):107-111 (1992).
19. Rubin CM, Larson RA, Anastasi J, Winter JN, Thangavelu M, Vardiman JW, Rowley JD, Le Beau MM. t(3;21)(q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76:2594-2598 (1990).
20. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14 (1995).
21. Albain KS, Le Beau MM, Ullirsh R, Schumacher H. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation. Genes Chromosomes Cancer 2:53-58 (1990).
22. Secker-Walker LM, Stewart EL, Todd A. Acute lymphoblastic leukaemia with t(4;11) follows neuroblastoma: a late effect of treatment? Med Pediat Oncol 13:48 (1985).
23. Archimbaud E, Charrin C, Guyotat D, Magaud JP, Gentilhomme L, Fiere D. Acute leukaemia with t(4;11) in patients previously exposed to carcinogens. Br J Haematol 69(4):467-470 (1988).
24. Jonveaux P, Hillion J, Bernard O, et al. Distinct MLL gene rearrangements associated with successive acute monocytic and lymphoblastic leukemias in the same patient. Leukemia 8:2224-2227 (1994).
25. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, et al. Identification of a gene (MLL) which spans the breakpoint in 1 Iq23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88(23):10735-10739 (1991).
26. Zeleznik-Le NJ, Harden AM, Rowley JD. 11q23 Translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci USA 91:10610-10614 (1994).
27. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 1 Iq23 chromosomal translocations. N Engl J Med 329:909-914 (1993).
28. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 91:12110-12114 (1994).
29. Nucifora G, Birn DJ, Espinosa R III, Erickson P, LeBeau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD. Involvement of the AML1 gene in the t(3;21) in therapyrelated leukemia and in chronic myeloid leukemia in blast crisis. Blood 81(10):2728-2734 (1993).
30. Pedersen-Bjergaard J, Philip P, Pedersen NT, Hou-Jensen K, Svejgaard A, Jensen F, Nissen NI. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II:Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients. Cancer 54:452-462 (1984).
31. Brusamolino E, Papa G, Valagussa P, Mandelli F, Bernasconi C, Marmont A, Bonadonna G, Tura S, Bosi A, Mango G, et al. Treatment-related leukemia in Hodgkin's disease: a multi-institution study on 75 cases. Hematol Oncol 5:83-98 (1987).
32. Iurlo A, Mecucci C, Van Orshoven A, Michaux JL, Boogaerts M, Noens L, Bosly A, Louwagie A, Van Den Berghe H. Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet 43:227-241 (1989).